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COMMENTARYToward tunable dynamic repression using CRISPRiSungyeon Jang, Sungho Jang, and Gyoo Yeol Jung*CRISPR interference (CRISPRi) is widely utilized for regulation of target
gene expression by repressing transcription. Simple design rules for the
single guide RNA (sgRNA) and multiplexity won this method immense
popularity. However, quantitative control of the expression levels at
varying degrees in a dynamic manner using CRISPRi has been regarded
difficult. To deal with this limitation, Fontana et al. modulated the
expression levels of the components of CRISPRi, the deactivated Cas9
(dCas9), and the sgRNAs, using various constitutive or inducible
promoters (Fontana et al., Biotechnol. J. 2018, 13, 1800069). They found
that the expression level of sgRNA is the key to controlling CRISPRi.
Modulation of sgRNA expression levels enabled quantitative tuning of the
CRISPRi-regulated gene expression level. This approach is expected to be
easily applied to diverse applications owing to its simplicity compared to
the conventional approaches that modified target sequence or changed the
expression level of dCas9.CRISPR/Cas systems are widely utilized for genome-wide
studies in which site-speciﬁc engineering are required.
Straightforward design rules for the targeting moiety, single
guide RNA (sgRNA), enables easy application of this method.
Beyond the wild-type Cas proteins with nuclease activity,
nuclease-deﬁcient Cas (dCas) proteins have been developed.
These mutant proteins can simply bind to the target locus and
repress transcription of nearby genes with the guidance of the
sgRNA. This system called CRISPR interference (CRISPRi)
can repress expression of multiple genes.[1,2] For ﬁne-tuning
the CRISPRi, methods for controlling the repression level of
CRISPRi have been studied. First, the spacer of sgRNA was
modiﬁed to change the binding region in the same gene[1] or
different genes.[3] Second, several sgRNAs were simulta-
neously expressed to control the tightness of the repression.[1]S. Jang, Dr. S. Jang, Prof. G. Y. Jung
Department of Chemical Engineering
Pohang University of Science and Technology
77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk, 37673, Korea
E-mail: gyjung@postech.ac.kr
Prof. G. Y. Jung
School of Interdisciplinary Bioscience and Bioengineering
Pohang University of Science and Technology
77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk, 37673, Korea
See accompanying article by Jason Fontana et al. DOI 10.1002/
biot.201800069
DOI: 10.1002/biot.201800152
Biotechnol. J. 2018, 13, 1800152 © 21800152 (1 of 2)Finally, dCas9 or sgRNA was placed
under inducible promoters to regulate
their expression levels in a dynamic
manner.[4,5] However, several limitations
of these approaches hindered their wide
use. When several sgRNAs are to be used,
sgRNAs with different repression efﬁ-
ciencies must be designed. Furthermore,
the inducible regulation of dCas9 exhib-
ited low fold repression and high leakage,
and ﬁne-control of the repression level
has not been demonstrated.
To overcome the drawbacks of the
conventional methods, Fontana et al.[6] reg-
ulated the expression level of sgRNA or
dCas9 using combinations of constitutive
andinduciblepromoters. In this study, itwas
shown that the regulation of the amount of
sgRNA was more effective than the regula-
tion of dCas9 tomodulate CRISPRi-induced
repression.When dCas9 or sgRNAwas fully
expressed with a strong promoter and theother machinery of CRISPRi was expressed at varying levels by
different constitutive promoters, the repression showed a linear
correlation with the varied promoter strengths (Figure 1).
Especially, when the expression of sgRNA was controlled by the
inducible promoter and that of dCas9 was controlled by a
constitutive promoter, the repression level changed up to 16-fold.
In addition, when allmachinery of CRISPRi was controlled by the
inducible promoter, the fold-change was further increased to 30-
fold. However, when the expression of dCas9 was not enough, the
repression level of CRISPRi could not be regulated by the
expression level of sgRNA. Therefore, it was shown that the dCas9
is the limiting component for CRISPRi. Additionally, CRISPRi
was able to maintain the repression even when the competing
sgRNA that could bind with the dCas9 but not bind with any
genomic locus is expressed.
In summary, the expression level of each part of CRISPRi was
quantitatively controlled to investigate its effect on the
repression. The amount of sgRNA signiﬁcantly contributed to
the overall repression level of CRISPRi. This work opens new
possibilities of the CRISPRi based on tunable dynamic
regulation of gene expression. Since only model systems were
demonstrated in this work, practical applications of this
approach are expected in future. In metabolic engineering,
ﬁne-tuning of gene expression is very important to improve
overall productivity, titer, or yield. Therefore, CRISPRi system
can be effectively used for quantitative control of multiple
pathway genes at the same time. Moreover, inducible control of
sgRNA could be adapted for dynamic control of metabolic ﬂux.
Finally, the system will also be applicable for predictable design
of genetic circuits for synthetic biology.018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Figure 1. Modulation of CRISPRi repression by controlling the expression
level of sgRNA. For CRISPRi repression, dCas9 and sgRNA form a
complex and bind to a target locus to block RNA polymerase (RNAP) for
gene expression. When dCas9 was fully expressed, the amount of sgRNA
determines the repression level of CRISPRi.
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